Harmony Biosciences Holdings (HRMY) Profit After Tax (2019 - 2025)
Historic Profit After Tax for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $50.9 million.
- Harmony Biosciences Holdings' Profit After Tax rose 1035.3% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.7 million, marking a year-over-year increase of 5141.77%. This contributed to the annual value of $145.5 million for FY2024, which is 1291.39% up from last year.
- As of Q3 2025, Harmony Biosciences Holdings' Profit After Tax stood at $50.9 million, which was up 1035.3% from $39.8 million recorded in Q2 2025.
- Harmony Biosciences Holdings' 5-year Profit After Tax high stood at $87.9 million for Q3 2022, and its period low was -$9.6 million during Q3 2021.
- Moreover, its 5-year median value for Profit After Tax was $34.3 million (2023), whereas its average is $33.0 million.
- Data for Harmony Biosciences Holdings' Profit After Tax shows a peak YoY increase of 5238518.52% (in 2021) and a maximum YoY decrease of 60392.88% (in 2021) over the last 5 years.
- Over the past 5 years, Harmony Biosciences Holdings' Profit After Tax (Quarter) stood at $22.7 million in 2021, then skyrocketed by 113.56% to $48.5 million in 2022, then plummeted by 45.15% to $26.6 million in 2023, then surged by 85.95% to $49.5 million in 2024, then rose by 2.81% to $50.9 million in 2025.
- Its Profit After Tax was $50.9 million in Q3 2025, compared to $39.8 million in Q2 2025 and $45.6 million in Q1 2025.